ask="5.63"
ask_size="200"
average_daily_volume="1438480"
bid="5.33"
bid_size="1700"
book_value="0.21"
change="-0.01"
change_from_200_day_moving_average="0.32"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-2.27"
change_From_52_week_low="2.36"
change_in_percent="-0.18%"
close="5.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71284000"
high="5.62"
high_52_weeks="7.80"
last_trade_date="2/14/2017"
last_trade_price="5.53"
last_trade_size="47174"
last_trade_time="4:00pm"
low="5.38"
low_52_weeks="3.17"
market_capitalization="585.96M"
moving_average_200_day="5.21"
moving_average_50_day="5.61"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="5.50"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="+6.13%"
percent_change_from_50_day_moving_average="-1.42%"
percent_change_from_52_week_high="-29.10%"
percent_change_from_52_week_low="+74.45%"
previous_close="5.54"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="26.63"
price_per_sales="20.79"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="12.76"
stock_exchange="NCM"
symbol="KERX"
volume="865917"
weeks_range_52="3.17 - 7.80"
